The human trophoblast cell-surface antigen 2 (TROP-2) expression on metastasized breast cancer
{{output}}
Purpose: The antibody-drug conjugates (ADCs) sacituzumab govitecan (SG) and datopotamab deruxtecan target trophoblast cell surface antigen 2 (TROP-2) and have shown significant efficacy in HER2-negative metastatic breast cancer (... ...
